Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite

Abstract Background Cancer stem cells (CSCs) are of great diagnostic importance due to their involvement in tumorigenesis, therapeutic resistance, metastasis and relapse. Method In this work, a sensitive electrochemical cytosensor was successfully established to detect HT-29 colorectal cancer stem c...

Full description

Bibliographic Details
Main Authors: Solmaz Sadi, Balal Khalilzadeh, Mahdi Mahdipour, Fatemeh Sokouti Nasimi, Ibrahim Isildak, Soodabeh Davaran, Mohammad-Reza Rashidi, Farhad Bani
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Cancer Nanotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12645-023-00208-4
_version_ 1797823029364916224
author Solmaz Sadi
Balal Khalilzadeh
Mahdi Mahdipour
Fatemeh Sokouti Nasimi
Ibrahim Isildak
Soodabeh Davaran
Mohammad-Reza Rashidi
Farhad Bani
author_facet Solmaz Sadi
Balal Khalilzadeh
Mahdi Mahdipour
Fatemeh Sokouti Nasimi
Ibrahim Isildak
Soodabeh Davaran
Mohammad-Reza Rashidi
Farhad Bani
author_sort Solmaz Sadi
collection DOAJ
description Abstract Background Cancer stem cells (CSCs) are of great diagnostic importance due to their involvement in tumorigenesis, therapeutic resistance, metastasis and relapse. Method In this work, a sensitive electrochemical cytosensor was successfully established to detect HT-29 colorectal cancer stem cells based on a nanocomposite composed of mesoporous silica nanoparticles (MSNs) and platinum nanoparticles (PtNPs) using a simple and fast electrodeposition technique on a glassy carbon electrode (GCE). Results According to SEM images, the PtNPs nanoparticles formed on the MSNs substrate are about 100 nm. As expected, high-rate porosity, increased surface-to-volume ratio, provides appropriate local electron transfer rate and suitable platform for the efficient formation of PtNPs. These features allow direct and stable binding of biotinylated monoclonal antibody of CD133 to streptavidin (Strep) and the subsequent availability of active sites for CSCs identification. Differential pulse voltammetry (DPV) results show that close interaction of CD133 + cells with monoclonal antibodies reduces charge transfer and electrical current, as confirmed by square wave voltammogram (SWV). Based on the recorded current versus number of CSCs, we noted that our developed system can sense CSCs from 5 to 20 cells/5 μL. Conclusions As a proof of concept, the designed nanobiocomposite was able to specifically detect CD133 + cells compared to whole HT-29 cells before magnetic activated cell sorting (MACS) process.
first_indexed 2024-03-13T10:17:33Z
format Article
id doaj.art-a0c53decfbc240a99ec4396991887cd3
institution Directory Open Access Journal
issn 1868-6958
1868-6966
language English
last_indexed 2024-03-13T10:17:33Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Cancer Nanotechnology
spelling doaj.art-a0c53decfbc240a99ec4396991887cd32023-05-21T11:08:45ZengBMCCancer Nanotechnology1868-69581868-69662023-05-0114111510.1186/s12645-023-00208-4Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocompositeSolmaz Sadi0Balal Khalilzadeh1Mahdi Mahdipour2Fatemeh Sokouti Nasimi3Ibrahim Isildak4Soodabeh Davaran5Mohammad-Reza Rashidi6Farhad Bani7Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesDepartment of Bioengineering, Faculty of Chemistry-Metallurgy, Yildiz Technical UniversityDepartment of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical SciencesDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical SciencesDepartment of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical SciencesAbstract Background Cancer stem cells (CSCs) are of great diagnostic importance due to their involvement in tumorigenesis, therapeutic resistance, metastasis and relapse. Method In this work, a sensitive electrochemical cytosensor was successfully established to detect HT-29 colorectal cancer stem cells based on a nanocomposite composed of mesoporous silica nanoparticles (MSNs) and platinum nanoparticles (PtNPs) using a simple and fast electrodeposition technique on a glassy carbon electrode (GCE). Results According to SEM images, the PtNPs nanoparticles formed on the MSNs substrate are about 100 nm. As expected, high-rate porosity, increased surface-to-volume ratio, provides appropriate local electron transfer rate and suitable platform for the efficient formation of PtNPs. These features allow direct and stable binding of biotinylated monoclonal antibody of CD133 to streptavidin (Strep) and the subsequent availability of active sites for CSCs identification. Differential pulse voltammetry (DPV) results show that close interaction of CD133 + cells with monoclonal antibodies reduces charge transfer and electrical current, as confirmed by square wave voltammogram (SWV). Based on the recorded current versus number of CSCs, we noted that our developed system can sense CSCs from 5 to 20 cells/5 μL. Conclusions As a proof of concept, the designed nanobiocomposite was able to specifically detect CD133 + cells compared to whole HT-29 cells before magnetic activated cell sorting (MACS) process.https://doi.org/10.1186/s12645-023-00208-4Cancer stem cellsCD133Platinum nanoparticlesSilica nanocompositeBiosensorColorectal cancer
spellingShingle Solmaz Sadi
Balal Khalilzadeh
Mahdi Mahdipour
Fatemeh Sokouti Nasimi
Ibrahim Isildak
Soodabeh Davaran
Mohammad-Reza Rashidi
Farhad Bani
Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
Cancer Nanotechnology
Cancer stem cells
CD133
Platinum nanoparticles
Silica nanocomposite
Biosensor
Colorectal cancer
title Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
title_full Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
title_fullStr Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
title_full_unstemmed Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
title_short Early stage evaluation of cancer stem cells using platinum nanoparticles/CD133 + enhanced nanobiocomposite
title_sort early stage evaluation of cancer stem cells using platinum nanoparticles cd133 enhanced nanobiocomposite
topic Cancer stem cells
CD133
Platinum nanoparticles
Silica nanocomposite
Biosensor
Colorectal cancer
url https://doi.org/10.1186/s12645-023-00208-4
work_keys_str_mv AT solmazsadi earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT balalkhalilzadeh earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT mahdimahdipour earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT fatemehsokoutinasimi earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT ibrahimisildak earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT soodabehdavaran earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT mohammadrezarashidi earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite
AT farhadbani earlystageevaluationofcancerstemcellsusingplatinumnanoparticlescd133enhancednanobiocomposite